Lv1
40 积分 2026-01-18 加入
AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists
7个月前
已完结
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
7个月前
已完结
Weight regain after cessation of GLP-1 drugs
7个月前
已关闭
皖公网安备34019202002308
